Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Anti-Inflammatory Effect of Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drops in an Endotoxin-Induced Uveitis Model

  • Bermúdez, María José
  • García-Otero, Xurxo
  • Mondelo-García, Cristina
  • González, Francisco
  • Pérez-Fernández, Román
  • Avila, Leandro
  • Antúnez, José
  • González-Barcia, Miguel
  • Adán, Alfredo
  • Aguiar, Pablo
  • Otero Espinar, Francisco Javier
  • Fernández Ferreiro, Anxo
[Abstract] Background: Uveitis is an infrequent disease which constitutes a major cause of ocular morbidity. Correct management is essential, being corticosteroids its cornerstone. In case of contraindication to corticosteroids or treatment failure, the use of topical tacrolimus (TAC) could be an alternative which has already demonstrated safety and effectiveness in other ocular pathologies. However, TAC eye drops are not marketed, thus their elaboration must be carried out in Hospital Pharmacy Departments (HPDs). Methods: 32 Sprague-Dawley rats were divided into 4 groups of 8 rats each: (a) untreated healthy rats (Healthy); (b) untreated Endotoxin-Induced Uveitis model-rats (EIU); (c) EIU-rats treated with standard treatment of dexamethasone ophthalmic drops (DXM) and (d) EIU-rats treated with TAC-hydroxypropyl-β-cyclodextrin eye drops previously developed by our group (TAC-HPβCD). The mRNA expression levels of IL-6, IL-8, MIP-1α and TNF-α, quantitative analysis of leucocytes in aqueous humor and histological evaluation were performed. Results: TAC-HPβCD eye drops demonstrated to reduce ocular inflammation, expression of IL-6, TNF-α, MIP-1α and leukocyte infiltration in aqueous humor. Conclusions: TAC-HPβCD eye drops showed beneficial effect in EIU model in rats, positioning as an alternative for uveitis treatment in case of corticosteroids resistance or intolerance., This project was partially funded by Health Research Institute Carlos III (PI20/00719, RETICS RD16/0008/0003), FEDER, Axencia Galega Innovación (Grupos de Potencial Crecimiento IN607B2020/11 y Grupo de Referencia Competitiva ED431C2021/01) and Spanish Ministry of Science, Innovation and Universities (RTI2018-099597-B-100). X. García-Otero is grateful to the IDIS (Health Research Institute of Santiago de Compostela) for financing his predoctoral research fellowship. C. Mondelo-García and A. Fernández-Ferreiro are grateful to the Carlos III Health Institute for financing their personnel contracts: JR20/00026 and JR18/00014., Xunta de Galicia; IN607B2020/11, Xunta de Galicia; ED431C2021/01
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Artificial Intelligence and Machine Learning Applications to Pharmacokinetic Modeling and Dose Prediction of Antibiotics: A Scoping Review

  • Varela Rey, Iria
  • Bandín Vilar, Enrique José
  • Toja-Camba, Francisco José
  • Cañizo-Outeiriño, Antonio
  • Cajade-Pascual, Francisco
  • Ortega Hortas, Marcos
  • Mangas-Sanjuan, Víctor
  • González Barcia, Miguel
  • Zarra Ferro, Irene
  • Mondelo-García, Cristina
  • Fernández Ferreiro, Anxo
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics13121203/s1, [Abstract]: Background and Objectives: The use of artificial intelligence (AI) and, in particular, machine learning (ML) techniques is growing rapidly in the healthcare field. Their application in pharmacokinetics is of potential interest due to the need to relate enormous amounts of data and to the more efficient development of new predictive dose models. The development of pharmacokinetic models based on these techniques simplifies the process, reduces time, and allows more factors to be considered than with classical methods, and is therefore of special interest in the pharmacokinetic monitoring of antibiotics. This review aims to describe the studies that use AI, mainly oriented to ML techniques, for dose prediction and analyze their results in comparison with the results obtained by classical methods. Furthermore, in the review, the techniques employed and the metrics to evaluate the precision are described to improve the compression of the results. Methods: A systematic search was carried out in the EMBASE, OVID, and PubMed databases and the results obtained were analyzed in detail. Results: Of the 13 articles selected, 10 were published in the last three years. Vancomycin was monitored in seven and none of the studies were performed on new antibiotics. The most used techniques were XGBoost and neural networks. Comparisons were conducted in most cases against population pharmacokinetic models. Conclusions: AI techniques offer promising results. However, the diversity in terms of the statistical metrics used and the low power of some of the articles make the overall assessment difficult. For now, AI-based ML techniques should be used in addition to classical population pharmacokinetic models in clinical practice., This work was partially supported by Axencia Galega Innovación (Grupos de Referencia Competitiva IN607A2023/04 and Excelencia (IN607D2023/05). I.V.-R., E.B.-V., F.J.T.-C., C.M.-G. and A.F.-F. acknowledge the support of the Instituto de Salud Carlos III (ISCIII) (research grants CM22/00055, CM20/00135, CM22/00146, JR20/00026 and JR18/00014). C.M.-G. and A.F.-F. acknowledge the support of the Instituto de Salud Carlos III (ISCIII) PI22/00038 and ICI21/00043., Xunta de Galicia; IN607A2023/04, Xunta de Galicia; IN607D2023/05